XML 55 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shared-Based Compensation
6 Months Ended
Jun. 30, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Shared-Based Compensation

Note 10. Shared-Based Compensation

During the three and six month periods ended June 30, 2014 and 2013, approximately $714 and $1,286 in 2014 and $664 and $1,094 in 2013, respectively, of compensation expense was recognized in selling, general and administrative expense for all share-based awards. During the six month period ended June 30, 2014, there were 97 share awards and 98 options awards to non-executive directors, officers and certain other key employees. During the six month period ended June 30, 2013, there were 95 share awards and 354 options awards to non-executive directors, officers and certain other key employees.

The restricted shares granted during the six month periods ended June 30, 2014 and 2013, vest pro-rata over three years. During the six month periods ended June 30, 2014 and 2013, we incurred $575 and $411, respectively, in expense related to restricted stock. The fair value of the shares issued was determined by using the grant date closing price of our common stock.

We incurred $711 and $683 of stock option expense in the six month periods ended June 30, 2014 and 2013, respectively. The fair value of our options cannot be determined by market value, as our options are not traded in an open market. Accordingly, the Black Scholes financial pricing model is utilized to estimate the fair value.

The following table provides a reconciliation of option activity for the six month period ended June 30, 2014:

 

Options

   Shares (000)     Weighted-
Average

Exercise
Price
     Weighted-
Average

Remaining
Contractual
Term
     Aggregate
Intrinsic Value
($000)
 

Outstanding at January 1, 2014

     1,233      $ 10.65         

Granted

     98      $ 19.69         

Exercised

     (65   $ 11.84         

Forfeited or expired

     (8   $ 12.62         
  

 

 

         

Outstanding at June 30, 2014

     1,258      $ 11.24         6.5       $ 17,995 (1) 
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at June 30, 2014

     882      $ 10.89         5.5       $ 12,964 (1) 
  

 

 

   

 

 

    

 

 

    

 

 

 

 

(1)  The intrinsic value is the amount by which the market price of our stock was greater than the exercise price of any individual option grant at June 30, 2014.